10.27
-0.70
(-6.38%)
At close: January 31 at 4:00:02 PM EST
10.27
-0.00
(-0.05%)
After hours: 7:56:37 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-55,745.81
-38,409.48
-24,356.73
-21,155.22
-21,967.64
Investing Cash Flow
22,132.67
-17,061.69
-3,709.36
-9,134.92
7,426.18
Financing Cash Flow
15,501.40
55,916.80
17,898.24
41,757.55
40,099.87
End Cash Position
35,389.28
43,823.19
43,374.75
53,551.28
42,096.78
Interest Paid Supplemental Data
32.96
34.30
26.52
15.94
33.23
Capital Expenditure
-401.79
-327.30
-219.36
-1,425.33
-112.64
Issuance of Capital Stock
13,809.98
55,827.51
17,769.62
41,455.63
39,688.12
Free Cash Flow
-56,147.60
-38,736.78
-24,576.09
-22,580.55
-22,080.28
12/31/2020 - 5/13/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CAPR Capricor Therapeutics, Inc.
15.04
-1.05%
CKPT Checkpoint Therapeutics, Inc.
2.8400
0.00%
MIST Milestone Pharmaceuticals Inc.
1.9700
-2.48%
VRNA Verona Pharma plc
57.30
+0.10%
AUPH Aurinia Pharmaceuticals Inc.
7.95
-0.63%
BCAB BioAtla, Inc.
0.4700
-0.84%
TGTX TG Therapeutics, Inc.
31.70
-4.98%
AVXL Anavex Life Sciences Corp.
9.27
-3.13%
CRDF Cardiff Oncology, Inc.
4.0300
+1.51%
ADMA ADMA Biologics, Inc.
16.15
+0.31%